Nutrien Sees Consensus Price Target Improvement Following Raised Guidance

On June 21st, Nutrien (TSX: NTR) raised their first half 2021 earnings per share guidance by $0.30 to $2.30 to $2.50 and announced that since the potash market has continued to tighten, they have upgraded capacity. They expect an additional half-million tonnes of potash of production output, after the June 7th half million tonne increase. These increases bring their expected potash sales volume to 13.3 – 13.8 million tonnes.

Off this news, a few analysts raised their 12-month price target on Nutrien, bringing their consensus 12-month price target to $66.71, up from $64.89, based on 20 analysts. Of those 20, three analysts have strong buy ratings, 13 have buy ratings, three have hold ratings and one analyst has a sell rating. The street high comes from Raymond James with an $82 price target and the lowest sits at $58 from Atlantic Equities.

BMO Capital Markets raised their 12-month price target to $70, from $65, and reiterated their outperform rating, calling this the dream scenario for Nutrien. The main reason for the raise is BMO marking-to-market their model for the recent fertilizer price surges and increased volume guidance by Nutrien. They believe that the average price now sits between $25-$70 per tonne but writes, “While we don’t see spot Brazil potash, NOLA urea, and Tampa DAP holding $500/t, $450/st or $660/t (all decade highs), we see prices still ending 2021E strong with Q4E averages of $425/t, $330/st and $520/t respectively.”

BMO believes that Nutrien can fill the gap for sanctions against Belarusian potash. They write, “We surmise NTR wants to make sure stakeholders understand NTR has much excess capacity in case the EU wants to really target Lukashenko.”

Below you can see BMO’s updated second quarter, 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Related News

Well Health: Consensus Price Target Climbs To $11.83 Following MyHealth Acquisition

WELL Health Technologies Corp. (TSX: WELL) this week announced that they would be acquiring MyHealth...

Thursday, June 10, 2021, 11:46:00 AM

Canaccord Cuts Kinross Gold’s Price Target To $9.50

Last week, Kinross Gold Corporation (TSX: K) announced the suspension of its Russian operations. The...

Monday, March 7, 2022, 10:22:35 AM

Antibe: Canaccord Raises Price Target After Q4 Results

On June 28th, Antibe Therapeutics (TSX: ATE) reported their fourth quarter and year-end financials. The...

Friday, July 2, 2021, 12:18:00 PM

BMO Drops Kinross Gold’s Price Target On Messy Q1 Results

On Monday Kinross Gold (TSX: K) reported its first quarter financial results. The company saw...

Thursday, May 12, 2022, 12:24:00 PM

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM